Table of Contents
Healthcare Investments in the Public Sector Will Increase Market Growth
Despite Brazilian economic and industry challenges, the market for reagent kits in in vitro diagnosis (IVD) is experiencing robust growth. This research service leverages primary research that includes several companies manufacturing and marketing reagent kits in IVD, companies distributing or buying these products, and IVD experts, as well as secondary research that includes web sites and magazines specializing in IVD, economic newspapers, and scientific databases. Market segments include immunochemistry, hematology/hemostasis, urinalysis, microbiology, molecular diagnostics, and point-of-care testing. The research service includes revenue, market share, and market analysis.
1. Internal Expertise
Frost & Sullivan uses the expertise of the global research staff supported by the internal databases to develop insights into the in vitro diagnostics market.
2. Primary Research
Primary research is focused on obtaining targeted information from key market participants (suppliers and end users) through phone interviews. Primary information traditionally constitutes 80 to 90% of the data provided in the research service.
3. Secondary Research
Secondary research was used to develop an understanding of the specific audiences targeted by clients. This research also assisted in identifying key participants for the primary interview stage and to provide high-level trends and context data.
=> The information was analyzed and aggregated to produce this research service.
General Key Findings
•Despite Brazilian economic and industry challenges, the market for reagent kits in in vitro diagnostics (IVD) is experiencing robust growth of about X to X% per year.
•In 2012, the Brazilian market for reagent kits in IVD generated $X billion in revenue. The market is expected to grow at a compound annual growth rate (CAGR) of X%, reaching $X billion in 2017.
The Brazilian Market for Reagent Kits in IVD—Market Trends Summary
Market Consolidation: Once there are more than X competitors, IVD companies constantly evaluate new acquisitions to achieve faster growth.
Reagent Kits Price: The federal government, which is the largest buyer of IVD products, presses companies to reduce the price of reagent kits.
Leased Equipment: About X% of analyzers/lab equipment are used in the free lease (rental) system. After the lab contracts to buy a certain volume of reagent kits, companies get the analyzers along with that commitment.
Reagent Kits Manufactured in Brazil: Reagent kits manufactured locally are increasing because the Brazilian government gives incentives for national companies; however, the amount manufactured locally is still very low. Almost X% of reagent kits are imported.
Segment Trends Summary
Immunochemistry: This segment is the largest in the Brazilian market for reagent kits in IVD, representing X% of the total revenue in 2012.
Hematology/Hemostasis: The coagulation sub-segment presented superior growth compared to the rest of the segment because with few competitors, there is less pressure to reduce prices.
Urinalysis: The automation in urinalysis tests grows X% per year, and the tests performed manually with biochemistry strips will drop substantially in the next few years.
Microbiology: bioMérieux introduced matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry technology, which is an instrument for microorganism identification through atomic mass that does not require reagents.
Molecular Diagnosis: This segment is very promising because molecular diagnosis provides high accuracy results for specific diseases that other IVD tests cannot identify or diagnose. The Brazilian molecular diagnosis segment is in a nascent growth stage. Even though this segment has the potential to increase, consolidation in this segment is restraining growth.
Point-of-care Testing (POCT): This segment represented a total market share of almost X% in 2012.
Competitive Landscape Summary
•The Brazilian market for reagent kits in IVD is highly fragmented, with the top X market participants, Roche Diagnostics, Siemens Healthcare, and Abbott Laboratories, controlling a combined market share of X%.
•Labtest is the largest private Brazilian company to manufacture locally reagent kits and is expanding its business to manufacture POCT and assembly analyzers in Brazil.
•Abbott Laboratories increased its market share in the molecular diagnosis segment because it is a continuous unique supplier for molecular diagnosis kits for the Brazilian federal government (tender bid).
•Siemens Healthcare is increasing its focus in the healthcare arena. The company strengthened its partnership with DASA Diagnostic Laboratory Group.
•The partnership renewal with Sysmex Corporation in 2012 contributed to Roche Diagnostics’ leadership role in the hematology/hemostasis segment.
•HORIBA, Ltd.; bioMérieux; and Alere are strong in the hematology/hemostasis, microbiology, and urinalysis segments, respectively.
Scope and Segmentation
Geographic coverage: Brazil
Study period: 2010–2017
Base year: 2012
Forecast period: 2013–2017
Monetary unit: US Dollars
Conversion rate: R$X = $X
This report covers revenue, market share, and market analysis of reagent kits used to perform IVD laboratory tests. This report does not assess sales and revenue of the equipment used in the laboratorial analysis. More thanX% of this equipment in diagnosis laboratories are under lease agreements tied to buying quantities stated in the contract between the manufacturer of the reagent kits/equipment and the diagnostic laboratory.
Market Segments Analysed in this Study
Key Questions This Study Will Answer
Is the market growing, how long will it continue to grow, and at what rate?
Are the existing competitors structured correctly to meet customer needs?
What are the most promising segments in the Brazilian market for reagent kits in IVD?
Which are the largest customers, and what is their market share in IVD product purchases?
What are the market drivers, restraints, and trends for the Brazilian market for reagent kits in IVD?
What are the opportunities and strategies to increase revenue and profit margins as well as increase participants’ market share?
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This new report from VPGMarketResearch.com contains 700 pages, 250 tables, and provides information not available from any other published source, including: - Specimen forecasts by market segment- Test ...
Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. VPGMarketResearch.com's new seven-country report is designed to help current suppliers and potential ...
This report contains 146 pages, 15 tables and presents a comprehensive analysis of the French flow cytometry market, including: Major issues pertaining to the French flow cytometry practice, as well as ...